Clinical trial
Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
NCT00004288 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004288 |
|---|---|
| Title | Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | University of Rochester |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | olsalazine |
| Enrollment | 4 |
| Start date | May 1, 1996 |
| Completion | Dec 1, 1999 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: